Evidence map›Paper›PMID 42517064›Full record

ArticleBreast cancer (Dove Medical Press)2026

Estrogen-Driven Breast Carcinogenesis in a Rat Model is Linked to Retroelement Activation and Inflammation and is Susceptible to Lamivudine Treatment.

Valentina Evdokimova, Zhenbo Zhang, Peter Ruzanov, Minsheng Hung, Naghmeh Khoshgoo, Suky Zheng, Mary Anne Quintayo, Lincoln D Stein, Jane Bayani, Laszlo Radvanyi

Abstract read
In one paragraph

Article in Breast cancer (Dove Medical Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Valentina Evdokimova *Ontario Institute for Cancer Research, Toronto, ON, Canada.
Zhenbo Zhang *Ontario Institute for Cancer Research, Toronto, ON, Canada.
Peter RuzanovOntario Institute for Cancer Research, Toronto, ON, Canada.
Minsheng HungOntario Institute for Cancer Research, Toronto, ON, Canada.
Naghmeh KhoshgooOntario Institute for Cancer Research, Toronto, ON, Canada.
Suky ZhengOntario Institute for Cancer Research, Toronto, ON, Canada.
Mary Anne QuintayoOntario Institute for Cancer Research, Toronto, ON, Canada.
Lincoln D SteinOntario Institute for Cancer Research, Toronto, ON, Canada.
Jane BayaniOntario Institute for Cancer Research, Toronto, ON, Canada.
Laszlo RadvanyiOntario Institute for Cancer Research, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite significant progress in treating estrogen receptor (ER)-positive breast cancer (BC), the recurrence risk remains high and mechanisms driving initial ductal tumorigenesis is unclear. Given an emerging role of LINE-1 (L1), HERV-K and other endogenous retroviral elements (EREs) in cancer, we tested the hypothesis that their expression can be induced by estrogen and blocked by treatment with lamivudine (3TC), an HIV-1 drug that can also inhibit Methods: This is a preclinical study using the well-established ACI rat model of spontaneous estrogen-driven BC to examine the earliest stages of cancer development and the effects of 3TC. Rat mammary glands and peripheral blood mononuclear cells (PBMCs) were analyzed by immunohistochemistry (IHC) and RNA sequencing (RNAseq). A panel of human BC cell lines and tissue microarrays (TMAs) were assessed by RT-qPCR, immunoblotting and IHC to evaluate ERE RNA and protein expression and a potential association with the ER- and FOXA1- positive BC. Results: Development of estrogen-induced ER Conclusion: Using a rat model, our study demonstrates estrogen dependent ERE expression in pre-invasive ER

Indexed as

ACI ratbreast cancerendogenous retroelementsestrogeninflammationlamivudine/3TC

Identifiers

PMID42517064
PMCPMC13404191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.